116 related articles for article (PubMed ID: 7614452)
1. Gelsolin: a candidate for suppressor of human bladder cancer.
Tanaka M; Müllauer L; Ogiso Y; Fujita H; Moriya S; Furuuchi K; Harabayashi T; Shinohara N; Koyanagi T; Kuzumaki N
Cancer Res; 1995 Aug; 55(15):3228-32. PubMed ID: 7614452
[TBL] [Abstract][Full Text] [Related]
2. [Tumor suppressive function of gelsolin].
Kuzumaki N; Tanaka M; Sakai N; Fujita H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1436-41. PubMed ID: 9309138
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of G2 checkpoint function by gelsolin transfection in human cancer cells.
Sakai N; Ohtsu M; Fujita H; Koike T; Kuzumaki N
Exp Cell Res; 1999 Aug; 251(1):224-33. PubMed ID: 10438588
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers.
Dosaka-Akita H; Hommura F; Fujita H; Kinoshita I; Nishi M; Morikawa T; Katoh H; Kawakami Y; Kuzumaki N
Cancer Res; 1998 Jan; 58(2):322-7. PubMed ID: 9443412
[TBL] [Abstract][Full Text] [Related]
5. Gelsolin gene therapy by retrovirus producer cells for human bladder cancer in nude mice.
Tanaka M; Sazawa A; Shinohara N; Kobayashi Y; Fujioka Y; Koyanagi T; Kuzumaki N
Cancer Gene Ther; 1999; 6(5):482-7. PubMed ID: 10505859
[TBL] [Abstract][Full Text] [Related]
6. [Progress of research on tumor suppressor genes].
Kuzumaki N
Hokkaido Igaku Zasshi; 1996 Mar; 71(2):133-7. PubMed ID: 8641669
[TBL] [Abstract][Full Text] [Related]
7. Loss of Gelsolin expression in human ovarian carcinomas.
Noske A; Denkert C; Schober H; Sers C; Zhumabayeva B; Weichert W; Dietel M; Wiechen K
Eur J Cancer; 2005 Feb; 41(3):461-9. PubMed ID: 15691647
[TBL] [Abstract][Full Text] [Related]
8. Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines.
Watanabe T; Shinohara N; Moriya K; Sazawa A; Kobayashi Y; Ogiso Y; Takiguchi M; Yasuda J; Koyanagi T; Kuzumaki N; Hashimoto A
IUBMB Life; 2000 Apr; 49(4):317-20. PubMed ID: 10995035
[TBL] [Abstract][Full Text] [Related]
9. [The mechanism for reduced expression of gelsolin, tumor suppressor protein, in bladder cancer].
Haga K
Hokkaido Igaku Zasshi; 2003 Jan; 78(1):29-37. PubMed ID: 12613021
[No Abstract] [Full Text] [Related]
10. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
11. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
13. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-143 as a tumor suppressor for bladder cancer.
Lin T; Dong W; Huang J; Pan Q; Fan X; Zhang C; Huang L
J Urol; 2009 Mar; 181(3):1372-80. PubMed ID: 19157460
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside G(M3) overexpression induces apoptosis and reduces malignant potential in murine bladder cancer.
Watanabe R; Ohyama C; Aoki H; Takahashi T; Satoh M; Saito S; Hoshi S; Ishii A; Saito M; Arai Y
Cancer Res; 2002 Jul; 62(13):3850-4. PubMed ID: 12097299
[TBL] [Abstract][Full Text] [Related]
16. Role of alternative splicing of periostin in human bladder carcinogenesis.
Kim CJ; Isono T; Tambe Y; Chano T; Okabe H; Okada Y; Inoue H
Int J Oncol; 2008 Jan; 32(1):161-9. PubMed ID: 18097555
[TBL] [Abstract][Full Text] [Related]
17. Translational studies of glutathione in bladder cancer cell lines and human specimens.
Pendyala L; Velagapudi S; Toth K; Zdanowicz J; Glaves D; Slocum H; Perez R; Huben R; Creaven PJ; Raghavan D
Clin Cancer Res; 1997 May; 3(5):793-8. PubMed ID: 9815751
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus mediated gelsolin gene therapy for orthotopic human bladder cancer in nude mice.
Sazawa A; Watanabe T; Tanaka M; Haga K; Fujita H; Harabayashi T; Shinohara N; Koyanagi T; Kuzumaki N
J Urol; 2002 Sep; 168(3):1182-7. PubMed ID: 12187264
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations in bladder carcinoma cell lines.
Cooper MJ; Haluschak JJ; Johnson D; Schwartz S; Morrison LJ; Lippa M; Hatzivassiliou G; Tan J
Oncol Res; 1994; 6(12):569-79. PubMed ID: 7787250
[TBL] [Abstract][Full Text] [Related]
20. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]